Carnegie Mellon University’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-46,970
| Closed | -$21.1K | – | 6 |
|
|
2024
Q1 | $21.1K | Hold |
46,970
| – | – | 0.03% | 5 |
|
|
2023
Q4 | $34.8K | Hold |
46,970
| – | – | 0.04% | 4 |
|
|
2023
Q3 | $40.9K | Hold |
46,970
| – | – | 0.05% | 5 |
|
|
2023
Q2 | $87.8K | Sell |
46,970
-1
| -0% | -$2 | 0.12% | 4 |
|
|
2023
Q1 | $174K | Hold |
46,971
| – | – | 0.12% | 3 |
|
|
2022
Q4 | $179K | Hold |
46,971
| – | – | 0.1% | 4 |
|
|
2022
Q3 | $371K | Hold |
46,971
| – | – | 0.21% | 3 |
|
|
2022
Q2 | $986K | Hold |
46,971
| – | – | 0.5% | 3 |
|
|
2022
Q1 | $1.77M | Hold |
46,971
| – | – | 0.74% | 3 |
|
|
2021
Q4 | $2.64M | Buy |
+46,971
| New | +$2.64M | 1.06% | 3 |
|